Listen as our Chief Scientific Officer, Dr. Lon Cardon, talks about what makes BioMarin’s approach to rare disease research both unique and powerful. We've spent the past 20 years building a mechanism that allows us to tackle any part of biology for any disease area.
--
BioMarin is a global biotechnology company focused on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases.
www.BioMarin.com
/ biomarinofficial
/ biomarin
/ biomarinofficial
14 ноя 2018
